CD34
+ cell dose effects on clinical outcomes after T‐cell replete haploidentical allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using peripheral blood stem cells. A study from the acute leukemia working Party of the European Society for blood and marrow transplantation (
EBMT
)
2000 ◽
Vol 26
(12)
◽
pp. 1325-1331
◽
2017 ◽
Vol 59
(7)
◽
pp. 1652-1658
◽
2003 ◽
Vol 9
(3)
◽
pp. 183-188
◽
2017 ◽
Vol 23
(2)
◽
pp. 278-284
◽
Keyword(s):
2012 ◽
Vol 89
(3)
◽
pp. 206-213
◽
2003 ◽
Vol 9
(3)
◽
pp. 183-188
◽